BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xing X, Chen S, Li L, Cao Y, Chen L, Wang X, Zhu Z. The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability - A Network Pharmacology and Transcriptomics Approach. Front Pharmacol 2018;9:525. [PMID: 29881350 DOI: 10.3389/fphar.2018.00525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Gui HL, Zhao CQ, Wang Y, Gu HT, Wang WJ, Cai W, Guo Q, Bao SS, Xu LM, Xie Q. Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis. J Clin Transl Hepatol 2020;8:277-84. [PMID: 33083250 DOI: 10.14218/JCTH.2020.00004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Li AP, He SS, Zhang WN, Zhang LC, Liu YT, Li K, Qin XM. Exploration the active compounds of Astragali Radix in treatment of adriamycin nephropathy by network pharmacology combined with transcriptomic approach. J Ethnopharmacol 2020;258:112537. [PMID: 31901455 DOI: 10.1016/j.jep.2019.112537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wu R, Dong S, Cai FF, Chen XL, Yang MD, Liu P, Su SB. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis. Molecules 2019;24:E338. [PMID: 30669350 DOI: 10.3390/molecules24020338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Zhang C, Yan Y, Gao X, Ma Y. [Therapeutic mechanism of the Mongolian medicine Qiwei Qinggan Powder against liver fibrosis based on UHPLC-TOF-MS combined with network pharmacological methods]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1131-41. [PMID: 34549702 DOI: 10.12122/j.issn.1673-4254.2021.08.02] [Reference Citation Analysis]
5 Ma R, Zhan Y, Zhang Y, Wu L, Wang X, Guo M. Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice. Drug Dev Res 2021. [PMID: 34927282 DOI: 10.1002/ddr.21905] [Reference Citation Analysis]
6 Hao W, He Z, Zhu H, Liu J, Kwek E, Zhao Y, Ma KY, He W, Chen Z. Sea buckthorn seed oil reduces blood cholesterol and modulates gut microbiota. Food Funct 2019;10:5669-81. [DOI: 10.1039/c9fo01232j] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
7 Fan Z, Guo C, Zhang Y, Yao J, Liao L, Dong J. Hongjingtian Injection Inhibits Proliferation and Migration and Promotes Apoptosis in High Glucose-Induced Vascular Smooth Muscle Cells. Drug Des Devel Ther 2019;13:4115-26. [PMID: 31827318 DOI: 10.2147/DDDT.S220719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Ni K, Cai X, Chen Y, Zhou L, Chen R, Zheng S, Wang Z. Determining Pharmacological Mechanisms of Chinese Incompatible Herbs Fuzi and Banxia in Chronic Obstructive Pulmonary Disease: A Systems Pharmacology-Based Study. Evid Based Complement Alternat Med 2020;2020:8365603. [PMID: 33488748 DOI: 10.1155/2020/8365603] [Reference Citation Analysis]
9 Tang Y, Liu M, Liu L, Zhen B, Wang T, Li N, Lv N, Zhu Z, Sun G, Wang X, Chen S. Lipophilic Constituents in Salvia miltiorrhiza Inhibit Activation of the Hepatic Stellate Cells by Suppressing the JAK1/STAT3 Signaling Pathway: A Network Pharmacology Study and Experimental Validation. Front Pharmacol 2022;13:770344. [DOI: 10.3389/fphar.2022.770344] [Reference Citation Analysis]
10 Zhu J, Li B, Ji Y, Zhu L, Zhu Y, Zhao H. β‑elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A‑VEGFA pathway based on network pharmacology. Oncol Rep 2019;42:2561-71. [PMID: 31638231 DOI: 10.3892/or.2019.7360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
11 Zhang Y, Zhu M, Zhang F, Zhang S, Du W, Xiao X. Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure. Front Pharmacol 2019;10:1046. [PMID: 31619994 DOI: 10.3389/fphar.2019.01046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]